DORCHESTER MINERALS, L.P. (DMLP): Nasdaq/NYSE listing notice — Dorchester Minerals manager Bill Russell dies; Nasdaq audit committee now non-compliant, cure period granted

DORCHESTER MINERALS, L.P.

C.W. 'Bill' Russell, manager and Advisory Committee member since 2004, passed away on October 30, 2025.
Advisory Committee reduced to two members, breaching Nasdaq audit committee minimum of three.
Nasdaq granted cure period until earlier of next annual meeting or October 30, 2026; if meeting before April 28, 2026, compliance due by then.
Partnership and General Partner intend to appoint a qualified replacement before cure period expires.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

DORCHESTER MINERALS, L.P. received a nasdaq deficiency notice notice regarding audit committee (rules 5615(a)(4)(C), 5605(c)(2)(A), 5605, 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5615(a)(4)(C), 5605(c)(2)(A), 5605, 5605(c)(4)

Exact text from the filing

November 10, 2025, the Partnership received a letter from Nasdaq acknowledging the Partnership’s non-compliance with Nasdaq’s audit committee requirements as set forth in Nasdaq’s Listing Rule 5605. The Nasdaq letter further provides that, consistent with Nasdaq’s Listing Rule 5605(c)(4), Nasdaq will provide the Partnership a cure period in order to regain compliance as follows: (a) until the earlier of the Partnership’s next annual unitholders’ meeting or October 30, 2026; or (b) if the next annual unitholders’ meeting is held before April 28, 2026, then the Partnership must evidence complian

View on SEC.gov

Browse all listing & compliance notices →

DORCHESTER MINERALS, L.P. filing history →

Source: SEC EDGAR

accession 0001437749-25-034432

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.